Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice

Nutrition and Cancer

Volumn 45, Issue 2, 2003, Pages 203-210

  Van Kranen, Henk J ^a   Mortensen, Alicja ^b   Sørensen, Ilona K ^b   Van den Berg Wijnands, Jolanda ^a   Beems, Rudolf ^a   Nurmi, Tarja ^c   Adlercreutz, Herman ^a   Van Kreijl, Coen F ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

^c FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; LIGNAN; LINSEED OIL; LINUSIT GOLD; MATAIRESINOL; PHYTOESTROGEN; SECOISOLARICIRESINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAN; CANCER PREVENTION; CARCINOGENESIS; CHEMICAL ANALYSIS; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; FEMALE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; LINSEED; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE K RAS; POINT MUTATION; RYE; RYE BRAN; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

ANIMALIA; SECALE CEREALE;

EID: 0043013255     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4502_10     Document Type: Article

References (51)

1. Doll R and Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI 66, 1191-1308, 1981.
2. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2, 427-442, 1991.
3. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96, 1027-1039, 1996.
4. American Institute for Cancer Research/World Cancer Research Fund. Food, Nutrition and the Prevention of Cancer: A Global Perspective. 1997. American Institute for Cancer Research, Washington.
5. Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. Nutritional Aspects of the Development of Cancer. Dept. Health Rep. Health Social Subjects 48, The Stationery Office, London, 1998.
6. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57-70, 2000.
7. Kinzler KW and Vogelstein B: Colorectal tumors. In The Genetic Basis of Human Cancer, Vogelstein Band Kinzler K (eds). New York: McGraw-Hill, 1998, pp 565-587.
8. Bienz M and Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103, 311-320, 2000.
9. Massague J and Chen YG: Controlling TGF-beta signaling. Genes Dev 14, 627-644, 2000.
10. Prescott SM and Fitzpatrick FA: Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470, M69-M78, 2000.
11. Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(Suppl 7), 103-112, 1995.
12. Adlercreutz H and Mazur W: Phyto-oestrogens and Western diseases. Ann Med 29, 95-120, 1997.
13. Axelson M, Sjovall J, Gustafsson BE, and Setchell KD: Origin of lignans in mammals and identification of a precursor from plants. Nature 298, 659-660, 1982.
14. Thompson LU: Experimental studies on lignans and cancer. Clin Endocrinol Metab 12, 691-705, 1998.
15. Mazur W: Phytoestrogen content in foods. Clin Endocrinol Metab 12, 729-742, 1998.
16. Powell SM, Zilz N, Beazerbarclay Y, Bryan TM, Hamilton SR, et al.: APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237, 1992.
17. Kinzler KW and Vogelstein B: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386, 761, 1997.
18. Smits R, Ruiz P, Diaz-Cano S, Luz A, Jagmohan-Changur S, et al.: E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology 119, 1045-1053, 2000.
19. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, et al.: Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3, 433-438, 2001.
20. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, et al.: A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 3, 429-432, 2001.
21. Shoemaker AR, Gould KA, Luongo C, Moser AR, and Dove WF: Studies of neoplasia in the Min mouse. Bba-Rev Cancer 1332, F25-F48, 1997.
22. Dove WF, Cormier RT, Gould KA, Halberg RB, Merritt AJ, et al.: The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos Trans R Soc Lond B 353, 915-923, 1998.
23. Moser AR, Pitot HC, and Dove WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324, 1989.
24. Shoemaker AR, Moser AR, and Dove WF: N-Ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res 55, 4479-4485, 1995.
25. Davies MJ, Bowey EA, Adlercreutz H, Rowland IR, and Rumsby PC: Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20, 927-931, 1999.
26. Sorensen IK, Kristiansen E, Mortensen A, Nicolaisen GM, Wijnands JA, et al.: The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett 130, 217-225, 1998.
27. van Kranen HJ, van Iersel PW, Rijnkels JM, Beems DB, Alink GM, et al.: Effects of dietary fat and a vegetable-fruit mixture on the development of intestinal neoplasia in the ApcMin mouse. Carcinogenesis 19, 1597-1601, 1998.
28. Mazur W, Fotsis T, Wahala K, Ojala S, Salakka A, et al.: Isotope dilution gas chromatographic- mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal Biochem 233, 169-180, 1996.
29. Nurmi T and Adlercreutz H: Sensitive high-performance liquid chromatographic method for profiling phytoestrogens using coulometric electrode array detection: application to plasma analysis. Anal Biochem 274, 110-117, 1999.
30. Wang GJ, Lapcik O, Hampl R, Uehara M, Al Maharik N, et al.: Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 65, 339-348, 2000.
31. Adlercreutz H, Wang GJ, Lapeik O, Hampl R, Wahala K, et al.: Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265, 208-215, 1998.
32. Stumpf K, Uehara M, Nurmi T, and Adlercreutz H: Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal Biochem 284, 153-157, 2000.
33. van Kranen HJ, de Gruijl FR, de Vries A, Sontag Y, Wester PW, et al.: Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis 16, 1141-1147, 1995.
34. Taubes G: Epidemiology faces its limits. Science 269,164-169, 1995.
35. Alabaster O, Tang Z, Frost A, and Shivapurkar N: Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16, 127-132, 1995.
36. Sinkeldam EJ, Kuper CF, Bosland MC, Hollanders VM, and Vedder DM: Interactive effects of dietary wheat bran and lard on N-methyl,N′-nitro-N-nitrosoguanidine-induced colon carcinogenesis in rats. Cancer Res 50, 1092-1096, 1990.
37. Kennedy AR, Beazerbarclay Y, Kinzler KW, and Newberne PM: Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res 56, 679-682, 1996.
38. Rao CV, Wang CX, Simi B, Lubet R, Kelloff G, et al.: Enhancement of experimental colon cancer by genistein. Cancer Res 57, 3717-3722, 1997.
39. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, and Fong HH: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165, 1996.
40. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, et al.: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921-927, 2000.
41. Pories SE, Ramchurren N, Summerhayes I, and Steele G: Animal models for colon carcinogenesis. Arch Surg 128, 647-653, 1993.
42. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, et al.: Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6, 1024-1028, 2000.
43. Gupta RA and Dubois RN: Combinations for cancer prevention. Nat Med 6, 974-975, 2000.
44. Oikarinen SI, Pajari A, and Mutanen M: Chemopreventive activity of crude hydroxsymatairesinol (HMR) extract in Apc(Min) mice. Cancer Lett 161, 253-258, 2000.
45. Mutanen M, Pajari AM, and Oikarinen SI: Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis 21, 1167-1173, 2000.
46. Petrik MB, McEntee MF, Chiu CH, and Whelan J: Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice. J Nutr 130, 1153-1158, 2000.
47. Wasan HS, Novelli M, Bee J, and Bodmer WF: Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci USA 94, 3308-3313, 1997.
48. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, et al.: Apc(Min), a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA 90, 8977-8981, 1993.
49. Chiu CH, McEntee MF, and Whelan J: Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res 57, 4267-4273, 1997.
50. Lione A and Scialli AR: The developmental toxicity of indomethacin and sulindac. Reprod Toxicol 9, 7-20, 1995.
51. Cormier RT and Dove WF: Dnmt1N/+reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/d6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele. Cancer Res 60, 3965-3970, 2000.